UB THERAPUTICS LTD
General Data
Reg Number
516743184
Sector
Biomed
Established
2023
No. of Employees
6
Stage
R&D
Additional Funding
1
Description
New drug therapy is based on a molecule with a new mechanism of action with a potential to be effective for not only for all patients who suffer from multiple myeloma, but also for patients who develop resistance to existing drugs
Technology
A new proteasome degradation inhibitor drug candidate with a distinct mode of action for the treatment of Multiple myeloma (MM).
Targeted Customers
Hospitals
Management personnel
Dima Ghannam-Shahbari - CEO & Co-Founder
Winning details
Route name
Winning year
Technological Incubators 2020
Technological Incubators 2020
2024
Technological Innovation Incubators Program – 2020 – Incubators Fund
Technological Innovation Incubators Program – 2020 – Incubators Fund
2026